FTSE MIB
33.987,67 -118,34 (-0,35%) Dow Jones
39.360,80 +52,80 (+0,13%) Nasdaq
18.357,24 +168,94 (+0,93%) Nikkei 225
40.912,37 -1,28 (-0,00%) Petrolio
83,12 -0,76 (-0,91%) Bitcoin EUR
52.180,75 -1.854,61 (-3,43%)
SCLX Dec 2024 1.000 call
| Chiusura precedente | 1,2000 |
| Aperto | 1,2000 |
| Denaro | 0,9000 |
| Domanda | 1,8000 |
| Prezzo d'esercizio | 1,00 |
| Scadenza | 2024-12-20 |
| Min-Max giorno | 1,2000 - 1,2000 |
| Contratto - Min-Max | N/D |
| Volume | |
| Open Interest | 14 |
GlobeNewswireScilex Holding Company Retains Warshaw Burstein, LLP and Christian Attar Law to Investigate Potential Naked Short Selling, Short Positions, Stock Lending Program Activities and Market Manipulation of Its Stock Price
PALO ALTO, Calif., Oct. 07, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, retains Warshaw Burstein, LLP and Christian Attar Law to investigate potential naked short selling activities, short positions, lending program activities and constitute market manipulation of its restricted sh
- GlobeNewswire
Scilex Holding Company Provides Notice to All Lenders of Short Positions in the Restricted Dividend Shares of Scilex Holding Company
PALO ALTO, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, provides notice to all lenders of short positions of restricted shares of Scilex common stock that were part of the previously announced dividend of Scilex common stock then-held by Sorrento Therapeutics, Inc.
- GlobeNewswire
Scilex Holding Company Provides Notice to All Record Holders and Beneficial Owners of Restricted Shares of Scilex Holding Company
PALO ALTO, Calif., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, provides notice to all record holders and beneficial owners of restricted shares of Scilex common stock that were part of the previously announced dividend of Scilex common stock then-held by Sorrento Therapeut
